Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Glycosaminoglycans Detected in Dried Urine Samples

By LabMedica International staff writers
Posted on 16 Jan 2013
Almost all patients with mucopolysaccharidoses (MPS) have increased levels of glycosaminoglycans (GAGs) in their urine, but transportation of liquid samples may be challenging. More...


As transportation of liquid urine samples in appropriate conditions for long distances, especially across international borders, could be difficult, urine samples dried onto filter paper could be a solution to the problem.

Scientists at the Portal Hospital de Clinicas (Porto Alegre, RS, Brazil) collected urine samples from untreated MPS patients and from healthy controls. Dried-urine filter paper (DUFP) were prepared with four rectangles measuring 15×40 mm of filter paper which were then completely dipped into the urine flasks for a few seconds and then dried at room temperature for at least four hours. A colorimetric method for total urinary GAG quantification was used with slight modification and is based in the reaction of GAGs with dimethylmethylene blue.

The scientists found that there were no differences in the concentration of GAGs between urine and DUFP samples Concentration of GAGs in DUFP samples of MPS patients never overlapped with that of normal controls. Untreated patients with MPS and normal controls were well discriminated using any of the samples. Creatinine concentration in liquid urine and DUFP samples was also determined and used as a correction factor. The concentration of GAG was found to be almost identical in liquid and DUFP samples in all the controls.

The authors concluded that conclude that determination of GAGs on DUFPs is comparable to the ones performed in liquid urine samples. Their incorporation by reference laboratories would provide an additional screening tool, which could be useful in particular circumstances and which could be made available along with the existing methods of GAG analysis. Handling and mailing of filter paper samples will facilitate the identification of MPS patients worldwide, especially when samples need to travel long distances and cross international borders, contributing to the earlier diagnosis and timely treatment of these diseases.

The mucopolysaccharidoses (MPS) are inherited metabolic disorders with bone, joint, and visceral abnormalities, leading to multiorgan dysfunction and, sometimes, neurological manifestations. The study was published in the January 2013 edition of the journal Clinica Chimica Acta.

Related Links:
Portal Hospital de Clinicas


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.